European HealthTech this week is characterised by EU‑level AI and data initiatives moving into implementation, fresh and upcoming funding calls for digital health innovators, and a continued tilt toward AI‑driven automation and consolidation plays as 2026 opens.​ European MedTech this week is shaped by three themes: MDR/IVDR simplification and EUDAMED timing, new guidance for Notified Bodies, and a steady drumbeat of innovation and capital around robotics, neuro and data‑rich

There has been a dynamic mix of significant funding, major EU policy initiatives, and next-generation technology integration in European HealthTech this week. The sector is clearly shifting towards scaling proven digital models and leveraging deep tech like AI and Extended Reality (XR). This week in European MedTech was dominated by significant regulatory developments, especially in the UK, alongside notable AI-focused product news and market concerns about global trade issue

Nelson Advisors partner Lloyd Price co-authored the Oxford University Venture Capital Network: Insights into Digital Health Report with Ava Chan - DPhil candidate in Biology, Ellena O’Keeffe -  MSc in Applied Cancer Science, Sili (Bobby) Qiu - DPhil candidate in Organic Chemistry, Adriana Mordente - DPhil candidate in Biology, Aneshka Moudry - MChem Chemistry.

The MedTech sector in 2026 stands at a pivotal juncture, defined by the convergence of rapid technological innovation, a maturing market demanding proven value, and a complex policy landscape. This report synthesizes these forces, moving from a macro-level analysis to specific, actionable insights. The industry is shifting from a focus on siloed technological advancements to an integrated, interconnected ecosystem where success hinges on the ability to operationalise innovati